Skip to main content
BFRI
NASDAQ Life Sciences

Shareholders to Vote on 133% Increase in Equity Incentive Plan Shares, Signaling Significant Future Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.08
Mkt Cap
$12.58M
52W Low
$0.536
52W High
$1.19
52W Position info
101% above low
Off High info
9.2% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

BFRI has more than doubled off its 52-week low of $0.536 on light trading volume (0.2× avg).

Summary

Biofrontera Inc. is asking shareholders to approve a 133% increase in its equity incentive plan, potentially diluting existing shares by nearly 30%, a critical move for talent retention amidst financial distress.


Key Events · Financing and Capital Events · BFRI

  • Proposed Share Increase for Incentive Plan

    Shareholders will vote on increasing the 2021 Omnibus Incentive Plan's authorized shares from 3,750,000 to 8,750,000, a 133% increase in the plan's share pool.

  • Significant Potential Dilution

    The proposed 5,000,000 additional shares for the incentive plan represent a potential dilution of approximately 29.85% of the company's current total voting shares.

  • Annual Meeting Scheduled

    The Annual Meeting of Stockholders is set for June 11, 2026, where these proposals, along with director elections and auditor ratification, will be voted upon.

  • Auditor Change Ratification

    Shareholders will ratify the appointment of CBIZ CPAs P.C. as the independent auditor for 2026, following Marcum LLP's resignation in 2025 due to an acquisition, with no reported disagreements.


Analysis · BFRI · Life Sciences

Biofrontera Inc. is seeking shareholder approval to significantly expand its 2021 Omnibus Incentive Plan, proposing to increase the total number of shares authorized for issuance from 3.75 million to 8.75 million. This 5 million share increase represents a potential dilution of approximately 29.85% of the company's current total voting shares. While the company states this expansion is essential for attracting and retaining key personnel, particularly in light of its previously disclosed substantial doubt about its ability to continue as a going concern and a Nasdaq delisting notice, this considerable potential dilution could significantly impact existing shareholders. The vote on this proposal is critical for the company's long-term compensation strategy and its operational continuity amidst financial challenges.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BFRI was trading at $1.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.6M. The 52-week trading range was $0.54 to $1.19. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BFRI - Latest Insights

BFRI
Nov 13, 2026, 4:46 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.700
Real-time Price: $0.890 info
Change: +$0.190 (+27%) info
Market Cap: $10.398M info
BFRI
Nov 13, 2026, 8:03 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.813
Real-time Price: $0.890 info
Change: +$0.077 (+9%) info
Market Cap: $10.398M info
BFRI
Oct 08, 2026, 9:25 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.9722
Real-time Price: $0.890 info
Change: -$0.0822 (-8%) info
Market Cap: $10.398M info
BFRI
Sep 14, 2026, 9:29 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.55
Real-time Price: $0.890 info
Change: -$0.660 (-43%) info
Market Cap: $10.398M info
BFRI
Aug 13, 2026, 4:41 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.27
Real-time Price: $0.890 info
Change: -$0.380 (-30%) info
Market Cap: $10.398M info